Lv3
240 积分 2024-12-10 加入
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
4天前
已完结
A novel GIP analogue, ZP 4165, enhances glucagon‐like peptide‐1‐induced body weight loss and improves glycaemic control in rodents
4天前
已完结
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation
5天前
已完结
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
11天前
已完结
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
12天前
已完结
The evolving landscape of obesity pharmacotherapy
15天前
已完结
Amylin
16天前
已关闭
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
16天前
已完结
The emerging safety profile of JAK inhibitors in rheumatic disease
19天前
已完结
Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes
1个月前
已完结
皖公网安备34019202002308
